HomeLEXXW • NASDAQ
add
Lexaria Bioscience
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Aug 2024info | Y/Y change |
|---|---|---|
Revenue | 84.00K | 173.25% |
Operating expense | 2.23M | 114.74% |
Net income | -2.18M | -76.29% |
Net profit margin | -2.60K | 35.48% |
Earnings per share | — | — |
EBITDA | -2.13M | -127.34% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Aug 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.56M | 343.63% |
Total assets | 8.87M | 187.54% |
Total liabilities | 1.21M | 199.26% |
Total equity | 7.66M | — |
Shares outstanding | 17.45M | — |
Price to book | 1.47 | — |
Return on assets | -56.79% | — |
Return on capital | -60.65% | — |
Cash Flow
Net change in cash
| (USD) | Aug 2024info | Y/Y change |
|---|---|---|
Net income | -2.18M | -76.29% |
Cash from operations | -1.89M | -16.65% |
Cash from investing | -69.59K | -1.68% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -1.96M | -8.14% |
Free cash flow | -1.10M | 12.77% |
About
Founded
2004
Website
Employees
7
